Skip to main content
. 2019 Jan 15;21(1):e11161. doi: 10.2196/11161

Table 1.

Study characteristics.

Study characteristics Quarter 1, n (%) Quarter 2, n (%) Quarter 3, n (%) Quarter 4, n (%) Quarter 5, n (%) Quarter 6, n (%) Total (N)
Telemedicine rounds 541 (11.84) 596 (13.04) 953 (20.86) 812 (17.77) 1074 (23.50) 593 (12.98) 4569
Infection and sepsis screenings 424 (9.70) 591 (13.51) 990 (22.64) 775 (17.72) 1030 (23.55) 563 (12.87) 4373
Scorings (SAPSa II and SOFAb) 541 (11.84) 596 (13.04) 953 (20.86) 812 (17.77) 1074 (23.51) 593 (12.98) 4569
Diagnostic recommendations 90 (12.21) 77 (10.45) 162 (21.98) 108 (14.65) 203 (27.54) 97 (13.16) 737
Therapeutic recommendations 111 (9.28) 82 (6.85) 285 (23.82) 202 (16.89) 363 (30.35) 153 (12.79) 1196
Total 3-h and 6-h bundles 20 (10.20) 18 (9.18) 36 (18.37) 41 (20.92) 60 (30.61) 21 (10.71) 196
Severe sepsis or septic shock detections 20 (10.20) 18 (9.18) 36 (18.37) 41 (20.92) 60 (30.61) 21 (10.71) 196
Mortality 10/20 (50) 8/18 (44.44) 14/36 (38.88) 10/41 (24.39) 14/60 (23.33) 7/21 (33.33) 63

aSAPS: Simplified Acute Physiology Score.

bSOFA: Sepsis-related Organ Failure Assessment.